ClinicalTrials.gg
CompletedNCT06816849H20KIDSUpdated Feb 10, 2025

Hydration in Children and Adolescents With Primary Headaches

An interventional study of Recommended water intake in Primary Headaches (Includes Migraines, Tension, Cluster Headaches), Hydration and Adolescent, sponsored by University Medical Centre Ljubljana. Completed at 1 site in Slovenia. Open to participants aged 4 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-02-10.

Sponsored by University Medical Centre Ljubljana · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Mar 2023, registered Jan 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
4 Years to 18 Years
Sex
All
01

Study summary

The aim of this study is to investigate the role of hydration and fluid intake in children and adolescents with primary headaches.

Read the detailed description

Headches are one of the key factors affecting or even limiting the health and well-being of children and adolescents. Lifestyle recommendations could help reduce the risk of chronic headaches and improve overall well-being in this population. In clinical practice, adequate fluid intake is one of the general recommendations for headache management. However, scientific literature on the role of hydration and fluid intake in headaches is limited. To date, all studies have been conducted on adults, and no studies have examined this topic in the pediatric population.

As the first interventional study investigating the impact of adequate fluid intake on headaches in children and adolescents, our study will make a significant contribution to understanding the role of hydration in headache management and developing recommendations for improving headache control in the pediatric population.

02

Conditions studied

  • Primary Headaches (Includes Migraines, Tension, Cluster Headaches)
  • Hydration
  • Adolescent
  • Children

Browse trials for

Keywords

  • primary headache
  • pediatric
  • children
  • hydration
  • water intake
03

In context

Cluster Headache

120 studies on the registry are indexed under Cluster Headache; 28 are open to participants now.

This study's enrollment of 60 is above the median of 42 across 88 interventional studies indexed under Cluster Headache.

Browse Cluster Headache studies →

Lead sponsor

University Medical Centre Ljubljana is the lead sponsor of 293 studies on the registry; 71 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 4-18 years.
  • Able to provide informed consent and willing to complete follow-up visits.
  • Primary headaches.
  • At least 1 headache per month.
  • Presence of headaches for at least 3 months or longer.

Exclusion criteria

Exclusion Criteria:

  • Secondary headaches.
  • Without headaches for 3 months or more.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Recommended fluid intake

    All participants received personalized consultation from a dietitian on adequate fluid intake and the selection of drinks based on dietary guidelines. They were required to follow the intervention for four months.

    Other: Recommended water intake

Interventions

  • OtherRecommended water intake

    All participants received personalized consultation from a dietitian on adequate fluid intake and the selection of drinks based on dietary guidelines. They were required to follow the intervention for four months.

06

What researchers measure

Primary outcomes

  1. Headache frequency

    Number of headache episodes over last three months.

    Time frame: 4 months

  2. Headache intensity

    Headache severity measured with the Visual Analog Scale (0 - 10).

    Time frame: 4 months

  3. Headache duration

    Average length of headache episode measured in minutes.

    Time frame: 4 months

Secondary outcomes

  1. Change in total body water

    Change in total body water (liter and %) assessed with bioelectrical impedance analysis (BIA 101 AKern) following the intervention.

    Time frame: 4 months

  2. Effect of nutritional advice on type of drink they have choosen

    Type of fluid they had increased during intervention.

    Time frame: 4 months

  3. Change in extracellular water

    Change in extracellular water (liter and %) assessed with bioelectrical impedance analysis (BIA 101 AKern) following the intervention.

    Time frame: 4 months

  4. Change in phase angle

    Change in phase angle (°) assessed with bioelectrical impedance analysis (BIA 101 AKern) following the intervention.

    Time frame: 4 months

07

Study locations

1 site
  • University Medical Centre Ljubljana
    Ljubljana, 1000, Slovenia
08

References and documents

Publications

  • Spigt MG, Kuijper EC, Schayck CP, Troost J, Knipschild PG, Linssen VM, Knottnerus JA. Increasing the daily water intake for the prophylactic treatment of headache: a pilot trial. Eur J Neurol. 2005 Sep;12(9):715-8. doi: 10.1111/j.1468-1331.2005.01081.x. PubMed 16128874 ↗
  • Spigt M, Weerkamp N, Troost J, van Schayck CP, Knottnerus JA. A randomized trial on the effects of regular water intake in patients with recurrent headaches. Fam Pract. 2012 Aug;29(4):370-5. doi: 10.1093/fampra/cmr112. Epub 2011 Nov 23. PubMed 22113647 ↗
  • Khorsha F, Mirzababaei A, Togha M, Mirzaei K. Association of drinking water and migraine headache severity. J Clin Neurosci. 2020 Jul;77:81-84. doi: 10.1016/j.jocn.2020.05.034. Epub 2020 May 20. PubMed 32446809 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2023 to primary completion in Oct 2023, 7 months.

Of 26 interventional studies with no phase under Cluster Headache, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 25. This study's 7 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 27, 2025
First posted
Feb 10, 2025
StartActual
Mar 1, 2023
Primary completionActual
Oct 31, 2023
CompletionActual
Jun 30, 2024
Last update
Feb 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06816849
Responsible party
Sponsor
First posted
Feb 10, 2025
Start date
Mar 1, 2023
Primary completion
Oct 31, 2023
Completion
Jun 30, 2024
Last update
Feb 10, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion